Chunlu Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chunlu Dong has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Ye
The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China
1 shared publication - Huaqing Shi
The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China
1 shared publication - Wence Zhou
The Second Clinical Medical School, Lanzhou University, Lanzhou, China
1 shared publication - Yanyan Lin
The First Clinical Medical School, Lanzhou University, Lanzhou
1 shared publication
Latest Publications
- Open Access
- 20 October 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (10) , 2598
Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy
Biliary tract cancer, encompassing intrahepatic and extrahepatic cholangiocarcinoma as well as gallbladder carcinoma, stands as a prevalent malignancy characterized by escalating incidence rates and unfavorable prognoses. The onset of cholangiocarcinoma involves a multitude of risk factors and could potentially be influenced by microbial exposure. The human microbiome, encompassing the entirety of human microbial genetic information, assumes a pivotal role in regulating key aspects such as host digestion, absorption, immune responses, and metabolism. The widespread application of next-generation sequencing technology has notably propelled investigations into the intricate relationship between the microbiome and diseases. An accumulating body of evidence strongly suggests a profound interconnection between biliary tract cancer and the human microbiome. This article critically appraises the existing evidence pertaining to the microbiome milieu within patients afflicted by biliary tract cancer. Furthermore, it delves into potential mechanisms through which dysregulation of the human microbiome could contribute to the advancement of biliary tract cancer. Additionally, the article expounds on its role in the context of chemotherapy and immunotherapy for biliary tract cancer.
- 20 October 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (10) , 2598
Open AccessInterplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy
Biliary tract cancer, encompassing intrahepatic and extrahepatic cholangiocarcinoma as well as gallbladder carcinoma, stands as a prevalent malignancy characterized by escalating incidence rates and unfavorable prognoses. The onset of cholangiocarcinoma involves a multitude of risk factors and could potentially be influenced by microbial exposure. The human microbiome, encompassing the entirety of human microbial genetic information, assumes a pivotal role in regulating key aspects such as host digestion, absorption, immune responses, and metabolism. The widespread application of next-generation sequencing technology has notably propelled investigations into the intricate relationship between the microbiome and diseases. An accumulating body of evidence strongly suggests a profound interconnection between biliary tract cancer and the human microbiome. This article critically appraises the existing evidence pertaining to the microbiome milieu within patients afflicted by biliary tract cancer. Furthermore, it delves into potential mechanisms through which dysregulation of the human microbiome could contribute to the advancement of biliary tract cancer. Additionally, the article expounds on its role in the context of chemotherapy and immunotherapy for biliary tract cancer.